Cita APA (7th ed.)

Ramjanee, S., Robertson, J., Franke-Fayard, B., Sinha, R., Waters, A., Janse, C., . . . Sinden, R. (2007). The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.

Cita Chicago (17th ed.)

Ramjanee, S., et al. The Use of Transgenic Plasmodium Berghei Expressing the Plasmodium Vivax Antigen P25 to Determine the Transmission-blocking Activity of Sera from Malaria Vaccine Trials. 2007.

Cita MLA (9th ed.)

Ramjanee, S., et al. The Use of Transgenic Plasmodium Berghei Expressing the Plasmodium Vivax Antigen P25 to Determine the Transmission-blocking Activity of Sera from Malaria Vaccine Trials. 2007.